ACVBP-R regimen: Difference between revisions
Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}} ==Overview== {{PAGENAME}} refers to a chemotherapy regimen consisting of (drugs) used in the treatment of (condition). =..." |
|||
Line 9: | Line 9: | ||
==Regimen== | ==Regimen== | ||
[[ | [[Cyclophosphamide|{{button|C – Cyclophosphamide}}]] | ||
[[ | [[Doxorubicin|{{button|H – Doxorubicin (Hydroxydaunomycin)}}]] | ||
[[Vincristine|{{button|O – Vincristine (Oncovin)}}]] | |||
[[Prednisone|{{button|P – Prednisone}}]] | |||
[[Rituximab|{{button|R – Rituximab}}]] | |||
==Indications== | ==Indications== |
Revision as of 22:43, 23 February 2015
WikiDoc Resources for ACVBP-R regimen |
Articles |
---|
Most recent articles on ACVBP-R regimen Most cited articles on ACVBP-R regimen |
Media |
Powerpoint slides on ACVBP-R regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on ACVBP-R regimen at Clinical Trials.gov Trial results on ACVBP-R regimen Clinical Trials on ACVBP-R regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on ACVBP-R regimen NICE Guidance on ACVBP-R regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on ACVBP-R regimen Discussion groups on ACVBP-R regimen Patient Handouts on ACVBP-R regimen Directions to Hospitals Treating ACVBP-R regimen Risk calculators and risk factors for ACVBP-R regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for ACVBP-R regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:
Overview
ACVBP-R regimen refers to a chemotherapy regimen consisting of (drugs) used in the treatment of (condition).
Regimen
H – Doxorubicin (Hydroxydaunomycin)